Status and phase
Conditions
Treatments
About
The purpose of the study is to evaluate the efficacy of saredutant in the treatment of Major Depressive Disorder in elderly patients.To evaluate the tolerability, safety and efficacy on disability and quality of life in patients with major depressive disorder.To evaluate safety and tolerability of 24 weeks of additional treatment in patients completing the initial 8-week treatment period.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The investigator will evaluate whether there are other reasons why a patient may not participate
Primary purpose
Allocation
Interventional model
Masking
393 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal